4R Phillip Dellinger,Mitchell M. Levy,Jean M. Carlet,Julian Bion,Margaret M. Parker,Roman Jaeschke,Konrad Reinhart,Derek C. Angus,Christian Brun-Buisson,Richard Beale,Thierry Calandra,Jean-Francois Dhainaut,Herwig Gerlach,Maurene Harvey,John J. Marini,John Marshall,Marco Ranieri,Graham Ramsay,Jonathan Sevransky,B Taylor Thompson,Sean Townsend,Jeffrey S. Vender,Janice L. Zimmerman,Jean-Louis Vincent.Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008[J].Critical Care Medicine.2008(1)
7Moritoki Egi,Rinaldo Bellomo,Edward Stachowski,Craig J. French,Graeme Hart.Variability of Blood Glucose Concentration and Short-term Mortality in Critically Ill Patients[J].Anesthesiology.2006(2)
5Van den Berghe G, Schetz M, Vlasselaers D, et al. Intensive insulin therapy incrically ill patients: NICE-SUGAR or Leuven blood glucose target. J Clin Endocrinol Metab, 2009, 94(1):3163-3170.
6Karakas A, Arslan E, Cakmak T, et al. Predictive Value of Soluble CD14, Interleukin-6 and Procaleitonin For Lower Extremity Amputation in People with Diabetes with Foot Ulcers: A Pilot Study.Pak J Med Sci, 2014,30(3):578-582.
7Kuo KC, Huang YH, Chen IL, et al. Are antibiotics beneficial to children suffering from enterovirus infection complicated with a high C-reactive protein level? Int J Infect Dis, 2014, 19(25):100-103.
8Mahalle N, Garg MK, Naik SS. Study of pattern of dyslipidemia. and its correlation with cardiovascular risk factors in patients with proven coronary artery disease. Indian J Endocrinol Metab, 2014, 18(1):48-55.
9VAN DEN BERGHE G,SCHETZ M,VLASSELAERS D, et al.Intensi insulin therapy incrically ill patients:NICE-SUGAR or Leuven bloc glucose target[J].JClin Endocrinol Metab,2009,94(9):3163-3170.
10M6rquez-Gonz61ez H, Mu oz-Ramirez MC, Ramfrez-Garcfa MA, et al. Hyperglycemia as a risk factor for mortality in critically ill neonates[J]. Rev Med Inst Mex SeguroSoc,2014,52 (2):104-109.
